Article
Levamisole resistance resolved at the single-channel level in Caenorhabditis elegans.
Department of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA.
The FASEB Journal (impact factor:
5.71).
09/2008;
22(9):3247-54.
DOI:10.1096/fj.08-110502
pp.3247-54
Source: PubMed
-
Article: Levamisole-activated single-channel currents from muscle of the nematode parasite Ascaris suum.
[show abstract] [hide abstract]
ABSTRACT: 1. The patch-clamp technique was used to examine levamisole-activated channels in muscle vesicles from Ascaris suum. Cell-attached and isolated inside-out patches were used. 2. Levamisole (1-90 microM), applied to the extracellular surface, activated channels which had apparent mean open-times in the range 0.80-2.85 ms and linear I/V relationships with conductances in the range 19-46 pS. Ion-replacement experiments showed the channels to be cation selective. 3. The kinetics of the channels were analysed. Generally open- and closed-time distributions were best fitted by two, and three exponentials respectively, indicating the presence of at least two open states and at least three closed states. The distributions of burst-times were best-fitted by two exponentials. 4. Channel open- and burst-times were voltage-sensitive: at low levamisole concentrations (1-10 microM), they increased with hyperpolarization. At higher concentrations of levamisole (30 microM and 90 microM) flickering channel-block was observed at hyperpolarized potentials. Using a simple channel-block model, values for the blocking dissociation constant, KB were determined as 123 microM at -50 mV, 46 microM at -75 mV and 9.4 microM at -100 mV. 5. At the higher concentration of levamisole (30 microM and 90 microM) long closed-times separating 'clusters' of bursts were observed, at both hyperpolarized and depolarized membrane potentials and this was interpreted as desensitization.British Journal of Pharmacology 02/1993; 108(1):170-8. · 4.41 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
antinematodal drug
C. elegans
Caenorhabditis elegans
currents
genetic level
lev-1 mutant C. elegans
LEV-1 mutants
LEV-10 knockouts
levamisole resistance
levamisole-activated whole muscle cell currents
model organism
nAChR channel currents
nAChRs aggregate
neuromuscular transmission
nicotinic acetylcholine receptor
nicotinic anthelmintic drug levamisole
single-channel level
single-channel recording
situ recordings
wild-type adults